210 related articles for article (PubMed ID: 35574218)
41. Myeloid/lymphoid neoplasm with a novel cryptic
Yang T; Mahmood N; Goldberg B; Cevallos J; Hsu P; Kolitz J; Cohen N; Zhang X
Leuk Lymphoma; 2023 Dec; 64(14):2338-2342. PubMed ID: 37791611
[No Abstract] [Full Text] [Related]
42. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome.
Li F; Zhai YP; Tang YM; Wang LP; Wan PJ
Genes Chromosomes Cancer; 2012 Sep; 51(9):890-7. PubMed ID: 22619110
[TBL] [Abstract][Full Text] [Related]
43. Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome.
Chase A; Grand FH; Cross NC
Blood; 2007 Nov; 110(10):3729-34. PubMed ID: 17698633
[TBL] [Abstract][Full Text] [Related]
44. Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion.
Dolan M; Cioc A; Cross NC; Neglia JP; Tolar J
Pediatr Blood Cancer; 2012 Jul; 59(1):194-6. PubMed ID: 22106025
[TBL] [Abstract][Full Text] [Related]
45. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13).
Popovici C; Adélaïde J; Ollendorff V; Chaffanet M; Guasch G; Jacrot M; Leroux D; Birnbaum D; Pébusque MJ
Proc Natl Acad Sci U S A; 1998 May; 95(10):5712-7. PubMed ID: 9576949
[TBL] [Abstract][Full Text] [Related]
46. miR-339 Promotes Development of Stem Cell Leukemia/Lymphoma Syndrome via Downregulation of the
Hu T; Chong Y; Lu S; Wang R; Qin H; Silva J; Kitamura E; Chang CS; Hawthorn L; Cowell JK
Cancer Res; 2018 Jul; 78(13):3522-3531. PubMed ID: 29735550
[TBL] [Abstract][Full Text] [Related]
47. Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.
Sootome H; Fujita H; Ito K; Ochiiwa H; Fujioka Y; Ito K; Miura A; Sagara T; Ito S; Ohsawa H; Otsuki S; Funabashi K; Yashiro M; Matsuo K; Yonekura K; Hirai H
Cancer Res; 2020 Nov; 80(22):4986-4997. PubMed ID: 32973082
[TBL] [Abstract][Full Text] [Related]
48. Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and poor prognosis.
Chen M; Wang K; Cai X; Zhang X; Chao H; Chen S; Shen H; Wang Q; Zhang R
Hematology; 2021 Dec; 26(1):153-159. PubMed ID: 33491601
[No Abstract] [Full Text] [Related]
49. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature.
Wakim JJ; Tirado CA; Chen W; Collins R
Leuk Res; 2011 Sep; 35(9):e151-3. PubMed ID: 21628071
[No Abstract] [Full Text] [Related]
50. Biphenotypic hematologic malignancy: a case report of the 8p11 myeloproliferative syndrome in a child.
Chen X; Zhang Y; Li Y; Lei P; Zhai Y; Liu L
J Pediatr Hematol Oncol; 2010 Aug; 32(6):501-3. PubMed ID: 20562652
[TBL] [Abstract][Full Text] [Related]
51. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases.
Wong WS; Cheng KC; Lau KM; Chan NP; Shing MM; Cheng SH; Chik KW; Li CK; Ng MH
Leuk Res; 2007 Feb; 31(2):235-8. PubMed ID: 16777224
[TBL] [Abstract][Full Text] [Related]
52. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.
Smedley D; Hamoudi R; Clark J; Warren W; Abdul-Rauf M; Somers G; Venter D; Fagan K; Cooper C; Shipley J
Hum Mol Genet; 1998 Apr; 7(4):637-42. PubMed ID: 9499416
[TBL] [Abstract][Full Text] [Related]
53. [Characteristic of 8p11 Myeloproliferative Syndrome with Rare Phenotype].
Xue S; Xu HX; Zhang YP; Liu FH; Lu YY; Li F; Wang YP; Wang CC; Jia XP; Wang JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):181-187. PubMed ID: 33554816
[TBL] [Abstract][Full Text] [Related]
54. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.
Walz C; Chase A; Schoch C; Weisser A; Schlegel F; Hochhaus A; Fuchs R; Schmitt-Gräff A; Hehlmann R; Cross NC; Reiter A
Leukemia; 2005 Jun; 19(6):1005-9. PubMed ID: 15800673
[TBL] [Abstract][Full Text] [Related]
55. 8p11 myeloproliferative syndrome: a review.
Jackson CC; Medeiros LJ; Miranda RN
Hum Pathol; 2010 Apr; 41(4):461-76. PubMed ID: 20226962
[TBL] [Abstract][Full Text] [Related]
56. B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature.
Trimaldi J; Carballido EM; Bowers JW; Anguiano AL; Zhang ZJ; Shah BD; Bruno S; List AF; Moscinski LC; Grady T; Agosti SJ; Kang L; Zhang L
Acta Haematol; 2013; 130(3):127-34. PubMed ID: 23594707
[TBL] [Abstract][Full Text] [Related]
57. The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase.
Hu T; Chong Y; Qin H; Kitamura E; Chang CS; Silva J; Ren M; Cowell JK
Oncogene; 2018 Apr; 37(14):1926-1938. PubMed ID: 29367757
[TBL] [Abstract][Full Text] [Related]
58. 8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes.
Belloni E; Trubia M; Gasparini P; Micucci C; Tapinassi C; Confalonieri S; Nuciforo P; Martino B; Lo-Coco F; Pelicci PG; Di Fiore PP
Genes Chromosomes Cancer; 2005 Mar; 42(3):320-5. PubMed ID: 15609342
[TBL] [Abstract][Full Text] [Related]
59. A case of acute myelogenous leukaemia characterised by the BCR-FGFR1 translocation.
Matikas A; Tzannou I; Oikonomopoulou D; Bakiri M
BMJ Case Rep; 2013 Mar; 2013():. PubMed ID: 23519513
[TBL] [Abstract][Full Text] [Related]
60. Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.
Chase A; Bryant C; Score J; Cross NC
Haematologica; 2013 Jan; 98(1):103-6. PubMed ID: 22875613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
